Abstract: The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of USP30, and the treatment of USP30-mediated disorders.
Type:
Grant
Filed:
September 11, 2020
Date of Patent:
December 19, 2023
Assignee:
Vincere Biosciences, Inc.
Inventors:
Donna L. Romero, Michael Garrett Johnson, Andrew David Lee, Bahareh Behrouz, Edward Lawrence Fritzen, Jr.